A ROW has erupted between the European Union, the United Kingdom and pharmaceutical company AstraZeneca over the supply of coronavirus vaccines.
The EU is frustrated at supply shortages and has demanded AstraZeneca doses be sent from British plants to make up for a shortfall.
Here’s what we know about the dispute and its potential implications:
What is the cause of the problem?
AstraZeneca has said initial deliveries to the EU will fall short because of a production glitch – said to be at a hub in Belgium – and it will not be able to meet its supply targets for the first three months of this year.
The Anglo-Swedish company announced initial deliveries in the EU would total approximately 31 million doses, rather than the anticipated 80 million in the first quarter of the year.
With the speed of the UK’s vaccine rollout outstripping other European countries, the EU has suggested doses produced in Europe have been directed elsewhere.
EU Commission president Ursula von der Leyen (below) has now called for an explanation from AstraZeneca for delivery hold-ups, as she insisted the supply orders are “binding” and “the contract is crystal clear”.
What else has the EU said?
EU health commissioner Stella Kyriakides has accused AstraZeneca of a “lack of clarity” and “insufficient explanations”, adding “the answers of the company have not been satisfactory” following a meeting on Monday.
She has proposed forcing all drug-makers to register their Covid-19 vaccine exports in advance, so the bloc can keep track of what they are doing.
Following talks on Wednesday, Kyriakides added: “We regret the continued lack of clarity on the delivery schedule.”
Latvian foreign affairs minister Edgars Rinkevics said states could take AstraZeneca to court for breach of supply contracts if it does not honour its delivery schedule.
And Germany’s health minister Jens Spahn supported restrictions on vaccine exports, saying Europe should have its “fair share”.
He added: “I can understand that there are production problems but then it must affect everyone in the same way.”
READ MORE: FACT CHECK: Claim Nicola Sturgeon is taking the EU's side in UK AstraZeneca row
Has AstraZeneca responded?
The company’s chief executive Pascal Soriot said the contract only committed to meet the EU’s demands to its “best effort”.
In an interview with Italy’s la Repubblica newspaper that was published on Tuesday, he said the EU’s deliveries were delayed in part because the bloc signed its contract three months later than the UK, and therefore EU manufacturing facilities were still catching up.
Translated by Politico, Soriot reportedly said the “contract is very clear: Our commitment is, I am quoting, ‘our best effort'”.
He explained that AstraZeneca and its partner Oxford University had signed a deal with the UK Government for 100 million doses three months before the EU deal for 400 million doses was agreed.
In response to the EU demanding their doses were shipped concurrently, Soriot suggested it was a “super stretch goal”, and added: “We said, ‘Okay, we’re going to do our best, we’re going to try, but we cannot commit contractually because we are three months behind UK’.”
What has the UK said?
Prime Minister Boris Johnson said this week he is “very confident” about the UK’s vaccine supply, while Cabinet Office minister Michael Gove insisted there “will be no interruption”.
Government vaccine tsar Nadhim Zahawi also said on Tuesday he is “confident” supply of the Pfizer jab – which is produced in Belgium – will continue.
Asked if the EU could prevent Pfizer vaccines from being exported, he told Sky News: “No, I’m confident that the Pfizer vaccine will be delivered.
“Pfizer have made sure that they have always delivered for us.
“They will continue to do so.”
But will UK supplies be affected?
The majority of the AstraZeneca/Oxford vaccine supply for the UK is manufactured here rather than at the Belgium plant so it is not expected to be disrupted.
But the EU’s threat to impose new rules on all vaccine manufacturers would affect access to the Pfizer vaccine, which is produced in Belgium.
The row would have to escalate further but if the EU went beyond asking for “early notification whenever [manufacturers] want to export vaccines to third countries” and were to impose actual export controls, then it could limit how many reach the UK.
The UK is scheduled to receive 3.5 million doses of the Pfizer vaccine over the next three weeks.
How many doses of vaccine has the UK ordered?
The UK Government has so far secured 40 million doses of the BioNTech/Pfizer vaccine, 100 million of the Oxford/AstraZeneca jab and 17 million from Moderna – the most-recently approved vaccine but supplies of it are not expected to arrive until spring.
The UK has also secured 60 million doses of the Novavax jab – to be produced on Teesside – with the hope that the Medicines and Healthcare products Regulatory Agency will approve it for use within weeks.
READ MORE: Nicola Sturgeon's plan to defy UK Government over vaccine data sparks Tory anger
How many doses does the UK currently have?
The UK Government has not published figures publicly on how many doses are currently available.
But with First Minister Nicola Sturgeon facing sustained criticism about the vaccination rollout in Scotland seemingly moving at a slower pace than in other parts of the UK – which the Scottish Government says is due to vaccinating higher proportions of care home residents first – she has suggested she could soon reveal supply figures.
Sturgeon said on Thursday: “I think we will just go back to publishing the actual supply figures from next week, so that we all have transparency around that.”
The Scottish Government did – briefly – publish the vaccine doses it had access to, but retracted the documents at the request of the UK Government over apparent concerns about other countries knowing how much is being supplied.
During his visit to Scotland on Thursday, the Prime Minister was asked about the possibility of more data being published.
He said: “We’re in favour of the maximum possible transparency that is compatible with security of supply. That’s the crucial thing, we’ve got to ensure we continue to have national security of supply.”
How is the rollout progressing in the UK?
As of Friday January 29, official figures showed 7,891,184 people in the UK had received a first dose of either the Pfizer or AstraZeneca vaccines.
A totals of 515,855 of those have been given in Scotland.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel